Gracell Biotechnologies Inc ADR (GRCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GRCL | CTMX | CSTL | ||
| Company | Gracell Biotechnologies Inc ADR | Cytomx Thera | Castle Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.26 | 4.50 | 23.59 | ||
| High | 10.28 | 4.63 | 24.61 | ||
| Low | 10.17 | 4.32 | 23.17 | ||
| Latest | 10.25 | 4.40 | 24.46 | ||
| Change | +0.01 | -0.05 | +0.77 | ||
| % Change | +0.05% | -1.12% | +3.25% | ||
| Volume | 6,417,100 | 2,422,900 | 341,300 | ||
| 20-Day Average Volume | 1,332,340 | 4,665,980 | 291,085 | ||
| Previous Close | 10.25 | 4.45 | 23.69 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.21 | 4.53 | 24.40 | ||
| 20-Day Raw Stochastic | 53.16% | 27.28% | 54.60% | ||
| 20-Day Relative Strength | 72.75 | 45.82 | 42.32 | ||
| Weighted Alpha | +228.20 | +122.13 | -8.21 | ||
| Today's Opinion | 100% Buy | 8% Buy | 72% Sell | ||
| Previous Opinion | 100% Buy | 8% Buy | 88% Sell | ||
| Last Month's Opinion | 100% Buy | 24% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.87% since 02/13/24 | -8.71% since 04/17/26 | -2.36% since 04/17/26 | ||
| Low | 10.09 on 02/16/24 | 4.32 on 04/24/26 | 23.17 on 04/24/26 | ||
| High | 10.35 on 02/14/24 | 5.07 on 04/20/26 | 25.72 on 04/21/26 | ||
| 1-Month | |||||
| %Chg | +2.60% since 01/19/24 | +3.77% since 03/24/26 | -3.51% since 03/24/26 | ||
| Low | 9.97 on 01/22/24 | 4.08 on 03/25/26 | 21.79 on 04/10/26 | ||
| High | 10.44 on 02/09/24 | 5.08 on 04/17/26 | 26.68 on 04/08/26 | ||
| 3-Month | |||||
| %Chg | +109.61% since 11/21/23 | -20.58% since 01/23/26 | -42.09% since 01/23/26 | ||
| Low | 3.80 on 11/28/23 | 4.08 on 03/25/26 | 21.79 on 04/10/26 | ||
| High | 10.44 on 02/09/24 | 8.21 on 03/16/26 | 44.28 on 01/26/26 | ||
| 6-Month | |||||
| %Chg | +222.33% since 08/21/23 | +34.97% since 10/24/25 | -0.20% since 10/24/25 | ||
| Low | 2.10 on 10/04/23 | 3.22 on 10/30/25 | 21.79 on 04/10/26 | ||
| High | 10.44 on 02/09/24 | 8.21 on 03/16/26 | 44.28 on 01/26/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 744,950 | 748,823 | 741,040 | ||
| Shares Outstanding, K | 72,678 | 170,187 | 30,296 | ||
| Annual Sales | 0 | 76,200,000 | 344,230,000 | ||
| Annual Net Income | -88,080,000 | -17,370,000 | -24,160,000 | ||
| Last Quarter Sales | 0 | 660,000 | 87,010,000 | ||
| Last Quarter Net Income | -9,270,000 | -26,510,000 | -2,330,000 | ||
| 60-Month Beta | -0.33 | 2.49 | 1.18 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 11/13/23 | -0.22 on 03/16/26 | -0.08 on 02/26/26 | ||
| Latest Earnings Date | 03/11/24 | 05/11/26 | 05/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||